清金化痰汤合二陈汤加减联合常规疗法治疗支气管扩张症急性加重期痰热壅肺证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.1

基金项目:

浙江省金华市科技计划项目(2022-4-398)


Clinical Study of Modified Qingjin Huatan Decoction plus Erchen Decoction Combined with Conventional Therapy in Treating Acute Exacerbation of Bronchiectasis with Phlegm-Heat Obstructing the Lung Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清金化痰汤合二陈汤加减联合常规疗法治疗支气管扩张症急性加重期痰热壅肺证的临 床疗效。方法:选取2021年10月—2024年6月在杭州市中医院武义分院住院治疗的120例支气管扩张症急性 加重期痰热壅肺证患者,按随机数字表法分为对照组与联合组各60例。对照组给予常规疗法治疗,联合组在 对照组基础上给予清金化痰汤合二陈汤加减治疗。比较2组临床疗效、症状及体征缓解时间、安全性,治疗前 后的中医证候评分、炎症因子[降钙素原(PCT)、超敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、 白细胞介素-17(IL-17)]、肺功能[第1秒用力呼气量(FEV1)、用力肺活量(FVC)、FEV1/FVC]、氧化应激 指标[活性氧(ROS)、丙二醛(MDA)、一氧化氮(NO)]、细胞间黏附分子-1(ICAM-1)、白三烯B4(LTB4) 和α-防御素1-3(HNP1-3) 水平。结果:联合组总有效率90.00%(54/60),高于对照组76.67%(46/60)(P< 0.05)。治疗后,2组咳嗽、咳痰、咯血、胸闷喘息、发热、口干等中医证候评分及总分均较治疗前降低(P< 0.05),联合组上述6项中医证候评分及总分均低于对照组(P<0.05)。联合组咳嗽、咳痰、咯血、肺部湿啰 音、气喘缓解时间均短于对照组(P<0.05)。2组PCT、IL-17、hs-CRP及TNF-α水平均较治疗前降低(P< 0.05),联合组PCT、IL-17、hs-CRP 及TNF-α 水平均低于对照组(P<0.05)。2 组FEV1、FVC 水平及FEV1/ FVC 值均较治疗前升高(P<0.05),联合组FEV1、FVC 水平及FEV1/FVC 值均高于对照组(P<0.05)。2 组 ROS、MDA及NO水平均较治疗前降低(P<0.05),联合组ROS、MDA及NO水平均低于对照组(P<0.05)。 2组ICAM-1、LTB4及HNP1-3水平均较治疗前降低(P<0.05),联合组ICAM-1、LTB4及HNP1-3水平均低于 对照组(P<0.05)。2组用药均安全性良好。结论:清金化痰汤合二陈汤加减联合常规疗法治疗支气管扩张症 急性加重期痰热壅肺证临床疗效好,可促进症状缓解,减轻炎症和氧化应激反应,改善肺功能,安全性好。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of modified Qingjin Huatan Decoction plus Erchen Decoction combined with conventional therapy in treating acute exacerbation of bronchiectasis with phlegm-heat obstructing the lung syndrome. Methods:A total of 120 patients with acute exacerbation of bronchiectasis with phlegm- heat obstructing the lung syndrome treated in Wuyi Branch of Hangzhou Hospital of Traditional Chinese Medicine from October 2021 to June 2024 were selected and divided into a control group and a combination group (n=60 per group) using a random number table method. The control group received conventional therapy, while the combination group received modified Qingjin Huatan Decoction combined with Erchen Decoction on the basis of the control group′s regimen. Clinical efficacy,symptom and sign relief time,and safety,as well as traditional Chinese medicine syndrome scores, inflammatory factors [procalcitonin(PCT), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α( TNF-α),and interleukin-17( IL-17)],pulmonary function [forced expiratory volume in one second( FEV1), forced vital capacity(FVC), and FEV1/FVC], oxidative stress indicators [reactive oxygen species (ROS), malondialdehyde (MDA), and nitric oxide (NO)], intercellular adhesion molecule-1 (ICAM-1), leukotriene B4( LTB4),and human neutrophil peptides 1-3( HNP1-3) levels before and after treatment,were compared between the two groups. Results:The total effective rate was 90.00% (54/60) in the combination group,higher than that of 76.67% (46/60) in the control group (P<0.05). After treatment, traditional Chinese medicine syndrome scores for cough,expectoration,hemoptysis,chest tightness and dyspnea,fever,and dry mouth,as well as the total score, decreased in both groups compared with those before treatment (P<0.05),and the combination group had lower scores than the control group (P<0.05). The combination group had shorter duration of cough,expectoration,hemoptysis, lung rales, and dyspnea relief than the control group (P<0.05). Levels of PCT, IL-17, hs-CRP, and TNF- α decreased in both groups compared with those before treatment (P<0.05),and the combination group had lower levels than the control group( P<0.05). FEV1 and FVC levels,and FEV1/FVC values increased in both groups compared with those before treatment (P<0.05),and the combination group had higher levels and values than the control group (P< 0.05). Levels of ROS,MDA,and NO decreased in both groups compared with those before treatment (P<0.05),and the combination group had lower levels than the control group (P<0.05). Levels of ICAM-1, LTB4, and HNP1-3 decreased in both groups compared with those before treatment (P<0.05),and the combination group had lower levels than the control group (P<0.05). Both groups of medications had good safety. Conclusion:Modified Qingjin Huatan Decoction combined with Erchen Decoction and conventional therapy is effective in treating acute exacerbation of bronchiectasis with phlegm-heat obstructing the lung syndrome. It can promote symptom relief, shorten symptom duration,reduce inflammation and oxidative stress responses,and has good safty.

    参考文献
    相似文献
    引证文献
引用本文

李春雅,张欣,张筱丹,陈晖.清金化痰汤合二陈汤加减联合常规疗法治疗支气管扩张症急性加重期痰热壅肺证临床研究[J].新中医,2025,57(23):7-13

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-12
  • 出版日期:
文章二维码